Six runners will take on the famous 26.1-mile Boston Marathon stretch from Hopkinton to Boston on April 20 to raise money for the UMass ALS Cellucci Fund.
An advanced smartphone application developed at Worcester Polytechnic Institute to help people with diabetes better manage their weight and blood sugar level and assess the status of chronic foot ulcers, is entering a pilot clinical study at UMass Medical School.
UMass Medical School researchers are using CRISPR/Cas9, a powerful gene editing tool, to develop a novel technology that can potentially cut the DNA of the latent HIV virus out of an infected cell.
Vanni Bucci, PhD, from UMass Dartmouth, is collaborating with colleagues in the UMass Center for Microbiome Research to sequence the intestinal microbiome with the goal of targeting treatments for specific enteric diseases and prototyping probiotic cocktails that could be used as a substitute for antibiotic treatment.
Based on the success of the Inflammatory Bowel Disease Anti-Inflammatory Diet, Barbara Olendzki is collaborating with colleagues in the UMass Center for Microbiome Research to uncover how exactly this diet affects gut bacteria.
Fecal transplant, a novel therapy that Randy Pellish, MD, is exploring with his patients who have recurrent C. diff, is proving to be more than 90 percent effective.
Roula N. Choueiri, MD, associate professor of pediatrics, offers advice to parents and caregivers concerned that their child might have an autism spectrum disorder.
Thanks to student volunteers from UMass Medical School, a special group of Central Massachusetts children have been provided an opportunity to learn to love tennis through the ACEing Autism program.
Good oral health is essential for overall health, and primary care doctors have an important role to play in their patients’ dental health. Family physician and oral health advocate Hugh Silk, MD, MPH, explains why and how in this Expert’s Corner video.
Dean Flotte, a gene therapy pioneer, will lead the influential journal at a pivotal time as gene therapies are emerging as approved, commercially-available medicines.